IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,509 | +35.5% | 28,705 | +122.9% | 0.00% | – |
| Q2 2023 | $35,798 | -16.3% | 12,878 | -45.2% | 0.00% | – |
| Q1 2023 | $42,791 | -67.8% | 23,513 | -9.8% | 0.00% | – |
| Q4 2022 | $133,000 | -24.4% | 26,069 | -26.1% | 0.00% | – |
| Q3 2022 | $176,000 | +44.3% | 35,282 | +8.5% | 0.00% | – |
| Q2 2022 | $122,000 | +76.8% | 32,519 | +162.4% | 0.00% | – |
| Q1 2022 | $69,000 | -2.8% | 12,391 | +6.5% | 0.00% | – |
| Q4 2021 | $71,000 | -77.0% | 11,637 | -63.4% | 0.00% | -100.0% |
| Q3 2021 | $309,000 | +66.1% | 31,821 | +144.1% | 0.00% | – |
| Q2 2021 | $186,000 | +82.4% | 13,038 | +205.3% | 0.00% | – |
| Q1 2021 | $102,000 | – | 4,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $4,180,000 | 0.56% |
| HARBOURVEST PARTNERS LLC | 335,709 | $2,041,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $586,000 | 0.20% |
| SHEETS SMITH WEALTH MANAGEMENT | 152,276 | $926,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 129,260 | $786,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 140,551 | $855,000 | 0.09% |
| Virtus ETF Advisers LLC | 28,969 | $176,000 | 0.07% |
| XTX Topco Ltd | 19,159 | $116,000 | 0.07% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 49,464 | $301,000 | 0.04% |
| Vident Investment Advisory, LLC | 168,476 | $1,024,000 | 0.03% |